Toward Autonomous Antibiotic Discovery
ABSTRACT Machines hold the potential to replace humans in many societal endeavors, and drug discovery is no exception. Antibiotic innovation has been stalled for decades, which has coincided with an alarming increase in multidrug-resistant bacteria. Since the beginning of the antibiotic era, the nat...
Guardado en:
Autor principal: | Cesar de la Fuente-Nunez |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
American Society for Microbiology
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c133d1e9befd4f2a903351f1aa649a05 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Artificial Intelligence and Antibiotic Discovery
por: Liliana David, et al.
Publicado: (2021) -
Antimicrobial Peptide Exposure Selects for Resistant and Fit <named-content content-type="genus-species">Stenotrophomonas maltophilia</named-content> Mutants That Show Cross-Resistance to Antibiotics
por: Paula Blanco, et al.
Publicado: (2020) -
The Neutrally Charged Diarylurea Compound PQ401 Kills Antibiotic-Resistant and Antibiotic-Tolerant <named-content content-type="genus-species">Staphylococcus aureus</named-content>
por: Wooseong Kim, et al.
Publicado: (2020) -
Microfluidics as a Novel Technique for Tuberculosis: From Diagnostics to Drug Discovery
por: Antonia Molloy, et al.
Publicado: (2021) -
Multiple Mutations in <named-content content-type="genus-species">Mycobacterium tuberculosis</named-content> MmpL3 Increase Resistance to MmpL3 Inhibitors
por: Matthew B. McNeil, et al.
Publicado: (2020)